MoneyWorks4Me

Mankind Pharma informs about disclosure

01 Mar 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the Company has received an Order on 28 February 2025 issued by Deputy Commissioner -State Tax, Nagpur under Section 73 of the CGST Act, 2017. The detailed disclosure as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/ PoD2/CIR/P/0155 dated November 11, 2024 as amended from time to time for aforesaid is enclosed as annexure I. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..